/assets/images/provider/photos/2835138.png)
Bupropion is a well known FDA approved medication primarily used for the treatment of depression and smoking addiction. Recently the medication has gained recognition for its use in weight loss particularly among obese patients and those with metabolic and psychiatric disorders linked to obesity. The use of bupropion in weight loss is an important aspect of the safe and effective use of the medication.
At MyHomeDoc Telehealth we practice evidence based medicine. This article is a thorough review of bupropion weight loss including pharmacology, clinical evidence, safety, mechanisms, dosage and guidelines for the use of the medication.
Weight loss is a complex process that involves metabolic behavioral and psychological factors. Pharmacologic therapy including bupropion is a complement to behavioral therapy which is the cornerstone of successful weight loss. By this review of mechanisms and clinical evidence patients and healthcare providers can make informed decisions about the use of bupropion in a comprehensive weight loss program.
Bupropion is a norepinephrine dopamine reuptake inhibitor (NDRI). The medication functions by regulating the levels of dopamine and norepinephrine which have a crucial role in regulating mood, energy and appetite. This mechanism is very important in weight loss because it addresses the psychological and physiological issues of overeating.
Bupropion is a drug that curbs cravings increases feelings of satiety and increases the urge to exercise. Patients on bupropion experience a decrease in emotional eating and snacking. The drug also curbs reward motivated eating which is a major concern in the treatment of obesity.
However unlike SSRIs bupropion has been observed to cause weight neutrality or mild weight loss rather than weight gain making it a superb choice for patients who are reluctant about the weight changes caused by medications.
Bupropion is presently approved by the FDA for the following uses:
Off Label Uses
Patients on bupropion for MDD or smoking cessation have been observed to experience modest yet significant weight loss thus making it a potential application beyond the boundaries of psychiatric disorders.
RCTs are extremely valuable in determining the use of bupropion for weight management. A 24 week RCT demonstrated that patients on bupropion experienced a weight loss of 4 to 5% of the initial body weight as compared to the placebo group. However when co-administered with naltrexone the weight loss was observed to increase to about 9% thus emphasizing the synergistic effect. These studies also emphasized improvements in waist circumference insulin sensitivity and lipid profiles.
The weight loss causing property of bupropion is most valuable when co-administered with lifestyle changes such as alterations in dietary patterns and increased levels of physical activity thus emphasizing the importance of a holistic approach to treatment.
Meta analyses of various RCTs have again confirmed the effectiveness of bupropion in weight loss. Furthermore the meta analyses have also confirmed the significant weight loss induced by bupropion particularly in obese patients, patients with depression and patients with type 2 diabetes. It is important to note that the meta analyses have emphasized the significance of the dose response relationship in weight loss and higher doses are more effective provided they are tolerated.
Systematic reviews have also indicated that long term adherence is an important consideration as the rate of weight loss is likely to plateau after a few months unless lifestyle changes are adhered to.
Real world evidence as reported by telehealth platforms such as MyHomeDoc Telehealth has indicated that patients have experienced a gradual and sustainable weight loss.

Bupropion targets both reward driven and homeostatic pathways to suppress appetite:
Dopamine pathways suppress reward driven appetite (craving high calorie foods).
Norepinephrine pathways suppress hunger and stimulate satiety. A 2019 study demonstrated a decrease in binge eating episodes in patients treated with bupropion directly attributing the result to bupropion. This mechanism is particularly helpful for patients who have emotional or compulsive eating patterns.
Recent studies have indicated that bupropion has the following effects:
These metabolic effects make bupropion an ideal adjunct treatment for patients with metabolic syndrome or type 2 diabetes. Although these effects are small they cumulatively contribute to the effect of appetite suppression and behavioral therapy to achieve significant weight loss.
Lifestyle changes can have a synergistic effect on bupropion. In a 2020 study published in the Journal of Obesity patients on bupropion with lifestyle changes of healthy eating and moderate physical activity lost a mean of 7% of initial body weight in 16 weeks almost twice the effect of pharmacotherapy alone.
MyHomeDoc Telehealth recommends that the most effective weight loss is achieved by an integrative approach that combines pharmacotherapy with counseling, dietary and exercise therapies.

Dosage is critical to ensure maximum efficacy and avoid adverse effects:
Standard Doses: 150 to 300 mg/day administered in one to two doses.
Individualized Doses: Tailored to the patient’s age, co-existing conditions and tolerance.
Monitoring: Overdose can lead to seizures, insomnia and hypertension.
The attending physician must tailor the treatment program to the patient’s needs and monitor the patient’s response closely.
Most side effects are temporary and can be managed by continuing the treatment or making slight modifications in the timing and dosage.
Seizures (dose related)
Hypertension or blood pressure surges
Severe allergic reactions
Physicians at MyHomeDoc Telehealth exercise extreme caution and review all medications before treatment to avoid interactions.
Contraindicated in patients with seizure disorders and bulimia
Use with extreme caution during pregnancy and lactation
Anxiety and mood symptoms must be closely monitored when treating ADHD and anxiety disorders
Bupropion has special uses in psychiatry that indirectly aid in weight loss:
Anxiety: Relieves depression and boosts energy without inducing somnolence.
ADHD: Enhances focus, lessens impulsivity and assists in modifying eating behaviors.
Bupropion indirectly helps patients in adhering to lifestyle changes by regulating emotional stimuli that provoke overeating.
Bupropion has moderate and long lasting weight loss effectiveness compared to other therapies:
Orlistat: Blocks fat absorption induces moderate weight loss and produces gastrointestinal side effects.
Liraglutide: GLP-1 receptor agonist, injectable more effective but costly.
Phentermine: Short acting appetite suppressant induces cardiovascular side effects.
The key advantage of bupropion is its dual action of facilitating weight loss and acting as an antidepressant making it the most preferred agent for patients with psychiatric and metabolic comorbidities.
Studies are currently underway for:
Combination therapies: Bupropion + naltrexone for enhanced efficacy.
Pharmacogenomics: Genetic testing for predictive purposes.
Telehealth implementation: Remote monitoring of patient compliance side effects and progress.
Artificial intelligence predictive analytics will soon be used to enable healthcare professionals to predict which patients will derive the greatest benefit further personalizing weight management strategies.
A patient with mild obesity and anxiety is started on bupropion 150 mg/day. With dietary and exercise modifications the patient loses 5% of body weight in 12 weeks along with decreased cravings and improved concentration. This case example illustrates the additive effect of pharmacologic and nonpharmacologic management.
Bupropion is a well established weight loss management medication that offers a unique combination of appetite suppression mild metabolic stimulation and mood elevation. There is evidence to support the use of bupropion in combination with lifestyle modifications appropriate dosing and close clinical monitoring for optimal efficacy.
Telehealth services such as MyHomeDoc Telehealth enable the safe prescribing, monitoring and management of patients for optimal long term outcomes. Although not a primary treatment bupropion is a useful adjunct to any patient seeking comprehensive and holistic weight loss management strategies.
Disclaimer: This article is for information purposes only and should not be considered a medical advice. Always consult a medical professional before taking any new medications.
Weight loss can be expected 4 to 6 weeks after starting bupropion treatment with gradual improvement over the next few months with lifestyle modifications.
Bupropion has been shown to be effective for both anxiety and ADHD. It is essential to monitor the patient closely for safe and effective use.
Recommended dose: 150 to 300 mg/day individualized for safety and efficacy.
Yes but some medications or supplements may increase the risk of seizures or decrease the effectiveness of the drug. Always consult a doctor.
Weight loss can be best sustained by sustaining lifestyle modifications. Stopping bupropion may result in a gradual return to normal weight.